A G Bostom

Summary

Publications

  1. ncbi Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Providence, USA
    J Am Soc Nephrol 10:164-6. 1999
  2. ncbi Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA
    Kidney Int Suppl 78:S246-52. 2001
  3. ncbi Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour
    A G Bostom
    Division of Renal Diseases, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA
    Ann Intern Med 135:133-7. 2001
  4. ncbi Cutaneous manifestations of end-stage renal disease
    L Robinson-Bostom
    Department of Dermatology, Brown University School of Medicine Rhode Island Hospital, Providence, 02903, USA
    J Am Acad Dermatol 43:975-86;quiz 987-90. 2000
  5. ncbi Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, 111 Brewster Street, Pawtucket, RI, USA
    Atherosclerosis 159:219-23. 2001
  6. ncbi Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA
    Circulation 101:2829-32. 2000
  7. ncbi Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA
    Transplantation 69:2128-31. 2000
  8. ncbi Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine
    A G Bostom
    Divisions of General Internal Medicine and Cardiology, Memorial Hospital of Rhode Island, Providence, RI 02860
    Arterioscler Thromb Vasc Biol 19:2241-4. 1999
  9. ncbi Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Providence 02860, USA
    Transplantation 68:257-61. 1999
  10. ncbi Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA
    Atherosclerosis 145:221-4. 1999

Detail Information

Publications23

  1. ncbi Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinine
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Providence, USA
    J Am Soc Nephrol 10:164-6. 1999
    ..131). Serum cystatin C levels may reflect subtle decreases in renal function that independently predict fasting total homocysteine levels among stable renal transplant recipients with a normal serum creatinine...
  2. ncbi Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA
    Kidney Int Suppl 78:S246-52. 2001
    ....
  3. ncbi Power Shortage: clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour
    A G Bostom
    Division of Renal Diseases, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA
    Ann Intern Med 135:133-7. 2001
    ..quot;..
  4. ncbi Cutaneous manifestations of end-stage renal disease
    L Robinson-Bostom
    Department of Dermatology, Brown University School of Medicine Rhode Island Hospital, Providence, 02903, USA
    J Am Acad Dermatol 43:975-86;quiz 987-90. 2000
    ..Cutaneous manifestations unique to kidney transplantation will not be covered. (J Am Acad Dermatol 2000;43:975-86.)..
  5. ncbi Proteinuria and plasma total homocysteine levels in chronic renal disease patients with a normal range serum creatinine: critical impact of true glomerular filtration rate
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, 111 Brewster Street, Pawtucket, RI, USA
    Atherosclerosis 159:219-23. 2001
    ....
  6. ncbi Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA
    Circulation 101:2829-32. 2000
    ..We evaluated whether a high-dose L-5-methyltetrahydrofolate-based regimen provided improved total homocysteine (tHcy)-lowering efficacy in chronic hemodialysis patients...
  7. ncbi Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patients
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA
    Transplantation 69:2128-31. 2000
    ....
  8. ncbi Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine
    A G Bostom
    Divisions of General Internal Medicine and Cardiology, Memorial Hospital of Rhode Island, Providence, RI 02860
    Arterioscler Thromb Vasc Biol 19:2241-4. 1999
    ..We conclude that serum cystatin C levels may reflect subtle decreases in renal function that independently predict fasting total homocysteine levels among stable-CAD patients with normal serum creatinine...
  9. ncbi Determinants of fasting plasma total homocysteine levels among chronic stable renal transplant recipients
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Providence 02860, USA
    Transplantation 68:257-61. 1999
    ....
  10. ncbi Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket 02860, USA
    Atherosclerosis 145:221-4. 1999
    ..As a result, renal transplant patients are a preferable high risk target population for controlled trials evaluating the tenable hypothesis that lowering total homocysteine levels will reduce cardiovascular disease outcomes...
  11. ncbi Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women
    A G Bostom
    Tufts Jean Mayer USDA Human Nutrition Research Center on Aging, Boston, Mass, USA
    Arch Intern Med 159:1077-80. 1999
    ..We examined whether elevated fasting plasma tHcy levels were predictive of all-cause and CVD mortality in a large, population-based sample of elderly US women and men...
  12. ncbi Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency
    A G Bostom
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Pawtucket, RI 02860, USA
    Atherosclerosis 156:227-30. 2001
    ..If controlled trials confirm that tHcy-lowering treatment reduces CVD events rates in RTR, these results should be applicable to CRI patients in general...
  13. ncbi Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort
    P F Jacques
    Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA
    Am J Clin Nutr 73:613-21. 2001
    ..Established determinants of fasting total homocysteine (tHcy) concentration include folate and vitamin B-12 status, serum creatinine concentration, and renal function...
  14. ncbi Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortification
    J Selhub
    Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA
    Public Health Rev 28:117-45. 2000
    ..The impact of fortification on the US population is likely to be similar; however it awaits the next survey for further confirmation...
  15. ncbi Renal insufficiency, vitamin B(12) status, and population attributable risk for mild hyperhomocysteinemia among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
    G Liaugaudas
    Division of General Internal Medicine, Memorial Hospital of Rhode Island, Providence, USA
    Arterioscler Thromb Vasc Biol 21:849-51. 2001
    ..5%). In the era of folic acid-fortified cereal grain flour, renal insufficiency and suboptimal vitamin B(12) status (but not folate status) contribute importantly to the PAR for mild hyperhomocysteinemia among patients with stable CAD...
  16. ncbi Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine
    H Han
    Frances Stern Nutrition Center, New England Medical Center, Boston, MA 02111, USA
    J Ren Nutr 11:149-54. 2001
    ..4 mg/dl)...
  17. ncbi Treatment of hyperhomocysteinemia in end-stage renal disease
    D Shemin
    Division of Renal Diseases, Rhode Island Hospital, Brown University School of Medicine, Providence, RI, USA
    Am J Kidney Dis 38:S91-4. 2001
    ..Data from this trial should be applicable to patients with chronic renal insufficiency in general...
  18. ncbi Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
    A Yango
    Division of Renal Diseases, Rhode Island Hospital, Providence, Rhode Island, USA
    Kidney Int 59:324-7. 2001
    ..The preponderance of hemodialysis patients (that is,> 90%) exhibits mild hyperhomocysteinemia refractory to treatment with either regimen...
  19. ncbi The kidney and homocysteine metabolism
    A N Friedman
    Vitamin Metabolism and Aging, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111, USA
    J Am Soc Nephrol 12:2181-9. 2001
    ..Efforts to resolve this important issue will advance the search for effective Hcy-lowering therapies in patients with renal disease...
  20. ncbi Residual renal function and mortality risk in hemodialysis patients
    D Shemin
    Renal Division, Rhode Island Hospital, Providence, RI 02903, USA
    Am J Kidney Dis 38:85-90. 2001
    ..In conclusion, the presence of residual renal function, even at a low level, is associated with a lower mortality risk in HD patients...
  21. ncbi Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey
    M S Morris
    Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111, USA
    Atherosclerosis 155:195-200. 2001
    ..Hyperhomocysteinemia and hypercholesterolemia could help to explain the increased risk for arteriosclerotic coronary artery disease in hypothyroidism...
  22. pmc Kidney function and risk of cardiovascular disease and mortality in kidney transplant recipients: the FAVORIT trial
    D E Weiner
    Tufts Medical Center, Boston, MA, USA
    Am J Transplant 12:2437-45. 2012
    ..73 m(2) . In conclusion, in stable kidney transplant recipients, lower eGFR is independently associated with adverse events, suggesting that reduced kidney function itself rather than preexisting comorbidity may lead to CVD...
  23. ncbi Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutrition
    D Shemin
    Division of Renal Diseases, Rhode Island Brown University School of Medicine, Providence, USA
    Perit Dial Int 20:439-44. 2000
    ....